Your browser doesn't support javascript.
loading
The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis.
Warrender-Sparkes, Matthew; Spelman, Tim; Izquierdo, Guillermo; Trojano, Maria; Lugaresi, Alessandra; Grand'Maison, François; Havrdova, Eva; Horakova, Dana; Boz, Cavit; Oreja-Guevara, Celia; Alroughani, Raed; Iuliano, Gerardo; Duquette, Pierre; Girard, Marc; Terzi, Murat; Hupperts, Raymond; Grammond, Pierre; Petersen, Thor; Fernandez-Bolaños, Ricardo; Fiol, Marcela; Pucci, Eugenio; Lechner-Scott, Jeannette; Verheul, Freek; Cristiano, Edgardo; Van Pesch, Vincent; Petkovska-Boskova, Tatjana; Moore, Fraser; Kister, Ilya; Bergamaschi, Roberto; Saladino, Maria Laura; Slee, Mark; Barnett, Michael; Amato, Maria Pia; Shaw, Cameron; Shuey, Neil; Young, Carolyn; Gray, Orla; Kappos, Ludwig; Butzkueven, Helmut; Kalincik, Tomas; Jokubaitis, Vilija.
Afiliação
  • Warrender-Sparkes M; Department of Medicine, University of Melbourne, Melbourne, Australia.
  • Spelman T; Department of Neurology, Royal Melbourne Hospital, Melbourne, Australia.
  • Izquierdo G; Hospital Universitario Virgen Macarena, Sevilla, Spain.
  • Trojano M; Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Italy.
  • Lugaresi A; MS Center, Department of Neuroscience, Imaging and Clinical Sciences, University 'G. d'Annunzio', Chieti, Italy.
  • Grand'Maison F; Neuro Rive-Sud, Hôpital Charles LeMoyne, Quebec, Canada.
  • Havrdova E; Department of Neurology and Center of Clinical Neuroscience, 1st Faculty of Medicine, General University Hospital and Charles University in Prague, Czech Republic.
  • Horakova D; Department of Neurology and Center of Clinical Neuroscience, 1st Faculty of Medicine, General University Hospital and Charles University in Prague, Czech Republic.
  • Boz C; Karadeniz Technical University, Trabzon, Turkey.
  • Oreja-Guevara C; University Hospital San Carlos, IdISSC, Madrid, Spain.
  • Alroughani R; Amiri Hospital, Kuwait City, Kuwait.
  • Iuliano G; Ospedali Riuniti di Salerno, Salerno, Italy.
  • Duquette P; Hôpital Notre-Dame, Montreal, Canada.
  • Girard M; Hôpital Notre-Dame, Montreal, Canada.
  • Terzi M; Ondokuz Mayis Üniversitesi, Samsun, Turkey.
  • Hupperts R; Orbis Medicle Center, Sittard, The Netherlands.
  • Grammond P; Hotel-Dieu de Levis, Quebec, Canada.
  • Petersen T; Aarhus University Hospital, Aarhus C, Denmark.
  • Fernandez-Bolaños R; Hospital Universitario Virgen de Valme, Seville, Spain.
  • Fiol M; FLENI, Buenos Aires, Argentina.
  • Pucci E; Ospedale di Macerata, Macerata, Italy.
  • Lechner-Scott J; John Hunter Hospital, Newcastle, Australia.
  • Verheul F; Groen Hart Ziekenhuis, Gouda, The Netherlands.
  • Cristiano E; Hospital Italiano, Buenos Aires, Argentina.
  • Van Pesch V; Cliniques Universitaires Saint-Luc, Brussels, Belgium.
  • Petkovska-Boskova T; Neurology Clinical Center, Skopje, Macedonia.
  • Moore F; Jewish General Hospital, Montreal, Canada.
  • Kister I; New York University Langone Medical Center, New York, USA.
  • Bergamaschi R; National Neurological Institute C. Mondino, Pavia, Italy.
  • Saladino ML; INEBA, Buenos Aires, Argentina.
  • Slee M; Flinders University and Medical Centre, Adelaide, Australia.
  • Barnett M; Brain and Mind Research Institute, Sydney, Australia.
  • Amato MP; Department NEUROFARBA, Section of Neurosciences, University of Florence, Florence, Italy.
  • Shaw C; Geelong Hospital, Geelong, Australia.
  • Shuey N; St Vincent's Hospital, Melbourne, Australia.
  • Young C; The Walton Centre for Neurology and Neurosurgery, Liverpool, United Kingdom.
  • Gray O; Craigavon Area Hospital, Portadown, United Kingdom.
  • Kappos L; University Hospital Basel, Neurology, Departments of Medicine, Clinical Research and Biomedicine, Basel, Switzerland.
  • Butzkueven H; Department of Medicine, University of Melbourne, Melbourne, Australia/ Department of Neurology, Box Hill Hospital, Monash University, Box Hill, Australia.
  • Kalincik T; Department of Medicine, University of Melbourne, Melbourne, Australia/Department of Neurology, Royal Melbourne Hospital, Melbourne, Australia.
  • Jokubaitis V; Department of Medicine, University of Melbourne, Melbourne, Australia vilija.jokubaitis@unimelb.edu.au.
Mult Scler ; 22(4): 520-32, 2016 Apr.
Article em En | MEDLINE | ID: mdl-26199347
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Desmielinizantes / Esclerose Múltipla Recidivante-Remitente / Adesão à Medicação / Substituição de Medicamentos / Cloridrato de Fingolimode / Imunossupressores Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Mult Scler Assunto da revista: NEUROLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Desmielinizantes / Esclerose Múltipla Recidivante-Remitente / Adesão à Medicação / Substituição de Medicamentos / Cloridrato de Fingolimode / Imunossupressores Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Mult Scler Assunto da revista: NEUROLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Austrália